Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $116,262 - $149,200
-656 Reduced 19.62%
2,687 $513,000
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $1.3 Million - $2.63 Million
-7,154 Reduced 68.15%
3,343 $724,000
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $1.39 Million - $1.94 Million
-4,569 Reduced 30.33%
10,497 $3.67 Million
Q4 2021

Feb 10, 2022

SELL
$347.28 - $421.83 $2.19 Million - $2.65 Million
-6,293 Reduced 29.46%
15,066 $5.73 Million
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $3.94 Million - $5.1 Million
-9,715 Reduced 31.26%
21,359 $8.66 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $3.91 Million - $5.05 Million
10,495 Added 51.0%
31,074 $14.7 Million
Q1 2021

May 12, 2021

BUY
$361.28 - $504.76 $566,848 - $791,968
1,569 Added 8.25%
20,579 $7.9 Million
Q4 2020

Feb 16, 2021

SELL
$292.7 - $370.96 $2.62 Million - $3.32 Million
-8,957 Reduced 32.03%
19,010 $7.03 Million
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $592,870 - $884,833
2,208 Added 8.57%
27,967 $8.64 Million
Q2 2020

Jul 31, 2020

SELL
$256.46 - $373.01 $22,568 - $32,824
-88 Reduced 0.34%
25,759 $9.54 Million
Q1 2020

May 07, 2020

BUY
$209.2 - $335.53 $148,532 - $238,226
710 Added 2.82%
25,847 $7.06 Million
Q4 2019

Jan 23, 2020

SELL
$288.29 - $335.49 $3.14 Million - $3.65 Million
-10,882 Reduced 30.21%
25,137 $8.34 Million
Q3 2019

Nov 01, 2019

SELL
$266.84 - $378.23 $5,336 - $7,564
-20 Reduced 0.06%
36,019 $11 Million
Q2 2019

Aug 07, 2019

BUY
$300.59 - $368.15 $178,851 - $219,049
595 Added 1.68%
36,039 $13.3 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $8.38 Million - $9.87 Million
30,744 Added 654.13%
35,444 $11 Million
Q4 2018

Feb 15, 2019

BUY
$272.46 - $366.54 $1.28 Million - $1.72 Million
4,700 New
4,700 $1.41 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.